Skip to main content

Blog

PPMD Announces Cardiac Care Workshop Report, Advancing Understanding of Heart Disease in Duchenne

...

WATCH: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping – Webinar Recording

...

Pat Furlong Advocates in Support of Adding Duchenne to the Ohio Newborn Screening Panel

...

WATCH: PPMD, NORD and PQHE Present ‘Living with Duchenne Muscular Dystrophy in 2023’

...

How You Can Be Involved in the First FDA Ad Comm Meeting for a Gene Therapy Product for Duchenne

...

Registration is Open! Join PPMD’s Annual Conference in Dallas

...

Sarepta Therapeutics Announces Advisory Committee Meeting will be Held for SRP-9001

...

Action Alert! Urge Congress to Support Progress in the Fight to End Duchenne

...

Duchenne Champions Reintroduce BENEFIT Act Heading into PPMD’s 2023 Advocacy Conference

...

Race Athlete Spotlight: Anita Mullick

...